Impaired Satiety Effect of GLP-1 Agonist in Obesity Is Associated With GLP-1 Resistance in Intestinal Afferent Nerves

被引：0
|
作者：
Al-Helaili, Alaa
Wang, Beini
Beyak, Michael
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1784
引用
收藏
页码：S842 / S842
页数：1
相关论文
共 50 条
  • [41] GLP-1 analogues in obesity: a cautionary tale
    Derrien, Elisa
    ACTUALITES PHARMACEUTIQUES, 2024, 63 (640):
  • [42] Pairing up with GLP-1 to combat obesity
    Crunkhorn, Sarah
    NATURE REVIEWS DRUG DISCOVERY, 2025, 24 (02) : 89 - 89
  • [43] The benefits of GLP-1 drugs beyond obesity
    Drucker, Daniel J.
    SCIENCE, 2024, 385 (6706) : 258 - 260
  • [44] A Role for GLP-1 in Treating Hyperphagia and Obesity
    Grill, Harvey J.
    ENDOCRINOLOGY, 2020, 161 (08)
  • [45] Endogenous GLP-1(7-36)amid (GLP-1):: Intestinal release and endocrine action in human
    Schirra, J
    Nicolaus, M
    Woerle, HJ
    Göke, B
    REGULATORY PEPTIDES, 2004, 122 (01) : 37 - 37
  • [46] Distinct activation of GLP-1 receptor by exendin-4 and GLP-1
    Montrose-Rafizadeh, C
    Yang, H
    Pritchette, LA
    Eng, J
    DIABETES, 1998, 47 : A192 - A192
  • [47] Pulmonary administration of GLP-1 (GLP-1 Technosphere powder) I: Kinetics
    Cassidy, J.
    Baughman, R.
    Costello, D.
    Levy, B.
    van Vliet, A.
    Diaz, M.
    Damico, C.
    Richardson, P.
    DIABETOLOGIA, 2008, 51 : S346 - S346
  • [48] Effect of GLP-1 upon lipid metabolism in morbid obesity
    Arnés, L
    Sancho, V
    Trigo, MV
    Martín-Duce, A
    González, N
    Valverde, I
    Villanueva-Peñacarrillo, ML
    DIABETOLOGIA, 2004, 47 : A55 - A55
  • [49] Down regulation of the GLP-1 receptor caused by GLP-1 is associated to increased receptor internalization.
    Brock, B
    Gregersen, S
    Hermansen, K
    DIABETOLOGIA, 1999, 42 : A199 - A199
  • [50] THE EFFECT OF GLP-1 ON GLUCOSE ELIMINATION
    TOFTNIELSEN, M
    MADSBAD, S
    HOLST, JJ
    DIABETOLOGIA, 1995, 38 : A169 - A169
12345